Bajaj Healthcare Ltd Share Price

Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE
₹320.15
+1.65+0.52% (1D)
As on 20 Nov 2026 at 15:52
As of 20 Nov 2026 at 15:52, Bajaj Healthcare Ltd is trading at ₹320.15. The 52-week range stands at ₹272.35–₹458.00, with a market cap of ₹1.08 thousand crore. At a P/E of 18.52 and a dividend yield of 0.47%, it is a small-cap stock in the Pharmaceuticals sector.

BAJAJHCARE Price Chart

Market Cap
₹1.08K Cr
PE Ratio
18.52
ROCE
10.75%

Bajaj Healthcare Ltd Performance

Bajaj Healthcare Ltd Fundamentals

Know More
Market Cap₹1.08K Cr
ROE10.45%
P/E Ratio (TTM)18.52
EPS (TTM)₹17.28
P/B Ratio1.94
Dividend Yield0.47%
Industry P/E91.72
Book Value₹165.37
Debt to Equity0.51
Face Value₹5

Bajaj Healthcare Ltd Shareholding Pattern

Know More
Promoter58.6%
Foreign Institutions2.1%
Mutual Funds1.7%
Domestic Institutions0.3%
Public37.4%

Bajaj Healthcare Ltd Financial Statements

Know More
No data for this view.

Bajaj Healthcare Ltd Peer Comparison

Know More
StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Sun Pharmaceutical Industries Ltd
₹1,885.10
-14.90(-0.78%)
4,52,298.61,583.7 - 2,046.9
Torrent Pharmaceuticals Ltd
₹4,698.80
87.80(+1.90%)
1,78,727.33,672.3 - 5,250.0
Dr Reddys Laboratories Ltd
₹1,390.50
-10.40(-0.74%)
1,16,144.51,101.0 - 1,414.9
Cipla Ltd
₹1,414.95
-3.55(-0.25%)
1,14,312.11,165.7 - 1,539.7
Lupin Ltd
₹2,010.00
11.20(+0.56%)
91,915.91,892.9 - 2,529.5

About Bajaj Healthcare

Incorporated in 1993, Maharashtra-based Bajaj Healthcare Limited is one of India's large scale and vertically integrated pharmaceutical manufacturer for quality-conscious customers. The Company is engaged in the manufacturing and exporting of Active Pharmaceutical Ingredient (APIs), Intermediates, Finished Dosage Forms & Nutraceuticals. It commenced the business operations in 1993 with a single unit at Tarapur. It became a public company in 2005 and listed its shares on the Indian Stock Exchange in FY2016. The Company operates API facilities at Tarapur, Savli and Panoli, and a formulations facility at Manjusar. In 2008, the Company acquired Formulations plant at Manjusar, Vadodara and have converted it into WHO-GMP compliant facility. In 2013, it set up another API and Intermediate manufacturing plant at Panoli, Ankleshwar and acquired and set up an Intermediate Unit in Tarapur MIDC, near Mumbai in November, 2014. The Company launched the initial public offer of 18,17,600 equity shares of Rs 10 each by raising funds of Rs 30.89 Cr, comprising a fresh issue of 1,49,600 equity shares amounting to Rs 2.54 Cr and the offer for sale of 16,68,000 equity shares amounting to Rs 28.35 Cr in May, 2016. In FY 2019-20, the Company acquired Intermediates manufacturing Unit at MIDC, Tarapur Maharashtra and also agreed to acquire Four Manufacturing facilities, comprising of three APIs manufacturing facilities, one Engineering Unit, at MIDC Tarapur, Maharashtra along with an Industrial Plot at Dahej, Gujarat. The Company started commercial operations at Panoli Unit, in Bharuch from May 11, 2022. In 2021-22, it launched a Nutraceutical named Magnesium L-Threonate; commenced commercial production at Tarapur, for Nimesulide API, used for relief from pain and prevention of fever. In 2023, the Company further launched 9 new molecules such as Glycine, Piperaquine phosphate, Amodiaquine hydrochloride, 4-7 DCQ, Hydroxy Novaldamine, 6-Chlorohexanone, Lafutidine, Zinc Ascorbate, Rivaroxaban in the Nutraceuticals, APIs, and Formulations segments. In FY 2024, Company expanded the operations in the Alkaloids manufacturing business. It established a new facility with the capacity to process approximately 250 metric tons of opium gum and around 2,500 metric tons of poppy straw. In June 2025, the Company acquired Genrx Pharmaceuticals Private Limited as a going concern.

Parent Organisation—
Founded1993
Managing DirectorSanjankumar R Bajaj
NSE SymbolBAJAJHCARE

Bajaj Healthcare Ltd Resistance and Support levels

R3323.40R2321.36R1320.09S1316.01S2314.74S3312.70320.15

Bajaj Healthcare Ltd Technicals

Current Price
₹320.15 ₹1.65 (+0.52%)
Bearish
7
Bullish
5
  • 20 Day0.3%
  • 50 Day0.7%
  • 100 Day1.8%
  • 200 Day7.0%

Bajaj Healthcare Ltd Latest News

View More
18 NOV 2026 | Wednesday
Bajaj Healthcare Limited’s employee stock options triggered allotment of 26,710 equity shares
09 OCT 2026 | Friday
Bajaj Healthcare to review financial results at a board meeting on October 17, 2026
23 SEPT 2026 | Wednesday
Bajaj Healthcare restricts trading for insiders pending financial results release in late 2026
03 SEPT 2026 | Thursday
Bajaj Healthcare announces record date for final dividend of Rs 1.50 per share
21 AUG 2026 | Friday
Bajaj Healthcare Limited’s employee stock option exercise yields Rs 12,500, increasing share capital
06 AUG 2026 | Thursday
India Ratings upgrades Bajaj Healthcare's bank loan facilities to IND A/Stable/IND A1
14 JUL 2026 | Tuesday
Bajaj Healthcare to conduct board meeting
29 JUN 2026 | Monday
Bajaj Healthcare surges after secures SEC recommendation for Cenobamate tablets
27 JUN 2026 | Saturday
Bajaj Healthcare secures SEC recommendation for Cenobamate tablets

2026

Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Quarterly ResultRelease dateCheck Latest financial

Frequently asked questions

The share price of Bajaj Healthcare Ltd is ₹320.15 as of 20 Nov 2026 at 15:52.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now